12
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5208 |
BAY-8002
BAY8002,BAY 8002 |
Monocarboxylate transporter | Membrane transporter/Ion channel |
BAY-8002 是一种可口服的单羧酸转运蛋白第 1 亚型 MCT1 选择性抑制剂,在表达 MCT1 的 DLD-1 细胞中,IC50值为 85 nM,具有抗肿瘤活性。 | |||
T3210 |
AZD3965
AZD 3965,AZD-3965 |
Monocarboxylate transporter | Membrane transporter/Ion channel |
AZD3965 (AZD-3965) 是单羧酸转运蛋白 1 (MCT1) 的选择性抑制剂,Ki 值为1.6 nM,比 MCT2的选择性高6倍。 | |||
T1768 |
7ACC2
|
Mitochondrial Metabolism; Monocarboxylate transporter | Membrane transporter/Ion channel; Metabolism |
7ACC2 是单羧酸盐转运蛋白抑制剂,IC50为 11 nM。它还是线粒体丙酮酸转运的有效抑制剂,可抑制乳酸涌入,通过抑制乳酸通量来发挥抗癌作用。 | |||
T14316 |
AR-C155858
|
Monocarboxylate transporter | Membrane transporter/Ion channel |
AR-C155858 是单羧酸转运蛋白 MCT1 和 MCT2 的抑制剂,Ki 分别为2.3和 10 nM。 | |||
T7460 |
α-Cyano-4-hydroxycinnamic acid
α-Cyano-4-hydroxycinnamic acid(α-CHCA),2-氰基-4-羟基 |
Monocarboxylate transporter | Membrane transporter/Ion channel |
α-Cyano-4-hydroxycinnamic acid (α-Cyano-4-hydroxycinnamic acid(α-CHCA)) 是非竞争性单羧酸盐转运蛋白 (MCTs) 抑制剂,可抑制线粒体丙酮酸转运蛋白,Ki 值为 6.3 μM。它可作为基质辅助激光解吸电离-飞行时间质谱 (MALDI-TOF) 分析的基质,可以促进肽离子化。 | |||
T5845 |
7ACC1
DEAC,香豆素D1421,Coumarin D 1421,7-(二乙胺基)-2-氧代-2-苯并吡喃-3-羧酸,7-(Diethylamino)coumarin-3-carboxylic acid,D 1421 |
Monocarboxylate transporter | Membrane transporter/Ion channel |
7ACC1 (D 142) 抑制表达MCT1和MCT4肿瘤细胞的乳酸涌入,能选择性干扰肿瘤微环境乳酸通量。 | |||
T67727 |
MCT1-IN-3
|
Monocarboxylate transporter | Membrane transporter/Ion channel |
MCT1-IN-3是一种单羧酸转运蛋白1 (MCT1)抑制剂。溶质载体(SLC)单羧酸转运蛋白1 (MCT1);SLC16A1)是治疗癌症的一个有希望的靶点。MCT1-IN-3(化合物24)对MCT1转运抑制作用强,IC50值为81.0 nM。MCT1-IN-3对多药转运体ABCB1也有明显的抑制作用。 | |||
T26221 |
MCT1-IN-2
SR13800,SR-13800,SR 13800 |
||
SR13800 is a monocarboxylate transporter 1 (MCT1) inhibitor with cell-permeable. | |||
T37822 | AR-C 141990 hydrochloride | ||
Monocarboxylate transporter (MCT1) inhibitor (pKi = 7.6. Exhibits approximately 10-fold selectivity for MCT1 over MCT2 and no significant activity against MCT3 or 4. Inhibits graft versus host response and prolongs cardiac graft survival in a rat model. Immunosuppressant. Also inhibits brain penetration of GHB analog HOCPCA. | |||
T37824 |
MCT4-IN-1
MCT4-IN-1 |
||
MCT4-IN-1 is an orally active and selective monocarboxylate transporter 4 (MCT4/SLC16A3) inhibitor with an IC50 of 77 nM and a Ki of 11 nM. MCT4-IN-1 targets to the cytosolic domain of MCT4. MCT4-IN-1 results in lactate efflux inhibition and reduction of cellular viability in MCT4 high expressing cells. MCT4-IN-1 has the potential for MCT4 transporter inhibition research[1]. | |||
T70903 |
KRH102053
|
||
KRH102053 is a HIF-1alpha inhibitor. KRH102053 decreased the protein level of HIF-1alpha and the mRNA levels of HIF-regulated downstream target genes, such as vascular endothelial growth factor, aldolase A, enolase 1 and monocarboxylate transporter 4. Consistent with these results, KRH102053 also inhibited the rates of HIF-related migration and invasion of HOS cells as well as the degree of tube formation in human umbilical vein endothelium cells. | |||
T68511 |
KRH102140
|
||
KRH102140 is a potent activator of PHD2. KRH102140, which has a structure similar to KRH102053. KRH102140 more efficiently suppressed HIF-1α than KRH102053 in human osteosarcoma cells under hypoxia. Furthermore, KRH102140 decreased the mRNA levels of HIF-regulated downstream target genes associated with angiogenesis and energy metabolism such as vascular endothelial growth factor, adrenomedullin, Glut1, aldolase A, enolase 1 and monocarboxylate transporter 4. KRH102140 also inhibited tube format... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2252 |
Syrosingopine
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
Syrosingopine 是 MCT1和 MCT4双重抑制剂,对 MCT4 的效力高 60 倍,可防止乳酸和 H+ 流出。它是可口服抗高血压药物,联合二甲双胍具有研究癌症疾病的潜力。 |